NCT04034342

Brief Summary

Physical inactivity in people with cerebral palsy (CP) has been linked with increased risk of cardiometabolic disease. Exercise studies rarely include people with CP with severe walking impairments and assess the sustainability of the intervention. RaceRunning allows people severe walking impairments to independently propel themselves using a running bike, which has a breast plate for support but no pedals. This project will assess the feasibility of at trial into the effectiveness of RaceRunning to reduce cardiometabolic disease risk factors and improve functional mobility. Intervention: Weekly standardised RaceRunning sessions over 6 months led by an experienced coach. Participants Twenty-five young people with CP aged 5-21, GMFCS levels III-V. Feasibility outcomes: Acceptability of RaceRunning, adherence and fidelity of the intervention, recruitment and retention rates and adverse events. Outcome measures: Cardiometabolic disease risk factors (physical activity, sedentary time, resting heart rate and blood pressure and aerobic capacity) and functional mobility assessed at baseline, 3 and 6 months. Quality of life (EQ-5D-Y) and health service use will inform a future cost-effectiveness analysis. Aspects of feasibility and acceptability and the variability and patterns of the change in outcomes will be reported using descriptive statistics.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
25

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Oct 2019

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 15, 2019

Completed
11 days until next milestone

First Posted

Study publicly available on registry

July 26, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2019

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 30, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2021

Completed
Last Updated

March 11, 2021

Status Verified

March 1, 2021

Enrollment Period

1.9 years

First QC Date

July 15, 2019

Last Update Submit

March 10, 2021

Conditions

Keywords

RaceRunning;cardiometabolic health desease riskfunctional mobility

Outcome Measures

Primary Outcomes (1)

  • maximum aerobic capacity (VO2max)

    an incremental test protocol will be used to measure the maximum oxygen uptake (ml/ min kg) an incremental test protocol will be used to measure maximum oxygen uptake (ml/min kg)

    Baseline, 12 weeks and 24 weeks

Secondary Outcomes (10)

  • Physical activity

    Baseline, 12 weeks and 24 weeks

  • sedentary behaviour

    Baseline, 12 weeks and 24 weeks

  • Resting heart rate (beats per min)

    Baseline, 12 weeks and 24 weeks

  • Resting heart rate blood pressure (mmHg)

    Baseline, 12 weeks and 24 weeks

  • Functional mobility Scale

    Baseline, 12 weeks and 24 weeks

  • +5 more secondary outcomes

Interventions

RaceRunning (www.racerunning.org) is a growing disability sport that provides an opportunity for people with moderate-to-severe CP to participate in exercise in the community. It allows those who are unable to walk independently, to propel themselves using a RaceRunning bike, which has a breastplate for support but no pedals. Participants sit on the saddle and use their legs to propel themselves forward.

Eligibility Criteria

Age5 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)
Sampling MethodNon-Probability Sample
Study Population

It is envisaged that the cohort will be recruited from a variety of RaceRunning clubs in Scotland: Meadowmill RaceRunning squad, Pitreavie AC (Dumfermline), if required Perth AC, Forth Valley Flyers, Ayr Seaforth AC and Glasgow Victoria Park AC. The participants in England will be recruited from Gloucester athletics club and Milestones school. The RaceRunning clubs and the study will be advertised through appropriate social media channels (Facebook, Twitter) and websites such as Scottish Disability Sport, Cerebral Palsy Scotland, CP Sport England etc. to further increase the recruitment potential.

You may qualify if:

  • A diagnosis of cerebral palsy or brain injury affecting coordination
  • Aged 5 to 21
  • GMFCS E-R level III, IV or V
  • Less than 15 hours of RaceRunning experience
  • Able to independently propel the bike for at least 30 meters
  • An ability to comprehend and follow instructions relating to participation in RaceRunning training

You may not qualify if:

  • Lower limb surgery
  • Having started Botox or other spasticity treatment less than 6 months prior to the start of the study
  • Severe visual impairment affecting the ability to safely take part in RaceRunning training sessions

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

University of Gloucestershire

Gloucester, United Kingdom

RECRUITING

Queen Margaret University

Musselburgh, EH21 6UU, United Kingdom

RECRUITING

Related Publications (1)

  • Ryan J, Theis N, Koufaki P, Phillips S, Anokye N, Andreopoulou G, Kennedy F, Jagadamma KC, vanSchie P, Dines H, van der Linden ML. Effect of RaceRunning on cardiometabolic disease risk factors and functional mobility in young people with moderate-to-severe cerebral palsy: protocol for a feasibility study. BMJ Open. 2020 Jul 1;10(7):e036469. doi: 10.1136/bmjopen-2019-036469.

MeSH Terms

Conditions

Motor ActivityCerebral Palsy

Condition Hierarchy (Ancestors)

BehaviorBrain Damage, ChronicBrain DiseasesCentral Nervous System DiseasesNervous System Diseases

Study Officials

  • Marietta L van der Linden, PhD

    Queen Margaret University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marietta van der Linden, PhD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior Research Fellow

Study Record Dates

First Submitted

July 15, 2019

First Posted

July 26, 2019

Study Start

October 1, 2019

Primary Completion

August 30, 2021

Study Completion

December 30, 2021

Last Updated

March 11, 2021

Record last verified: 2021-03

Locations